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Abstract
Purpose—Trichloroethylene (TCE) is an industrial solvent associated with liver cancer, kidney 
cancer, and non- Hodgkin’s lymphoma (NHL). It is unclear whether an excess of TCE-associated 
cancers have occurred surrounding the Middlefield–Ellis–Whisman Superfund site in Mountain 
View, California. We conducted a population- based cancer cluster investigation comparing the 
incidence of NHL, liver, and kidney cancers in the neighborhood of interest to the incidence 
among residents in the surrounding four-county region.
Methods—Case counts and address information were obtained using routinely collected data 
from the Greater Bay Area Cancer Registry, part of the Surveillance, Epidemiology, and End 
Results program. Population denominators were obtained from the 1990, 2000, and 2010 US 
censuses. Standardized incidence ratios (SIRs) with two- sided 99 % confidence intervals (CIs) 
were calculated for time intervals surrounding the US Censuses.
Results—There were no statistically significant differences between the neighborhood of interest 
and the larger region for cancers of the liver or kidney. A statistically significant elevation was 
observed for NHL during one of the three time periods evaluated (1996–2005: SIR = 1.8, 99 % CI 
1.1–2.8). No statistically significant NHL elevation existed in the earlier 1988–1995 (SIR = 1.3, 
99 % CI 0.5–2.6) or later 2006–2011 (SIR = 1.3, 99 % CI 0.6–2.4) periods.
Conclusion—There is no evidence of an increased incidence of liver or kidney cancer, and there 
is a lack of evidence of a consistent, sustained, or more recent elevation in NHL occurrence in this 
neighborhood. This evaluation included existing cancer registry data, which cannot speak to 
specific exposures incurred by past or current residents of this neighborhood.
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Purpose
The association between trichloroethylene (TCE) and cancer risk has recently received 
increased attention [1–5], in part due to 2011 results from the United States Environmental 
Protection Agency (US EPA) that provided evidence for associations between TCE exposure 
and kidney, liver, and non-Hodgkin’s lymphoma (NHL) cancers [6, 7]. The International 
Agency for Research on Cancer subsequently re-classified TCE as “carcinogenic to 
humans” [8]. TCE is a manufactured chlorinated solvent used until the 1990s as an industrial 
solvent within manufacturing and industrial facilities for a variety of purposes [4, 9]. US 
EPA Superfund sites have been defined as areas where large volumes of TCE have been 
released [10]. The Middlefield–Ellis–Whisman (MEW) Superfund Study Area (or MEW 
Site) in Mountain View, California, has been the subject of environmental investigation and 
remediation since the 1980s, due to contamination related to industrial, manufacturing, and 
military operations of responsible parties described in detail elsewhere. (Note: the MEW 
Site is comprised of several Superfund sites: Fair- child Semiconductor Corp.—Mountain 
View Superfund site, Raytheon Company Superfund site, Intel Corp.— Mountain View 
Superfund site, several other facilities, and portions of the former Naval Air Station Moffett 
Field Superfund site) [11].
The Greater Bay Area Cancer Registry (GBACR)—a population-based cancer registry 
comprising the nine county region around the San Francisco Bay Area—received a call from 
a media representative regarding a possible increase in cancer incidence due to TCE 
exposure in the residential area of Mountain View closest to the MEW site’s vapor intrusion 
pathways. Population-based cancer registries in the USA do not collect data on exposures or 
environmental risk factors. However, cancer registries routinely collect information on 
residential address at the time of diagnosis for cancer patients, which enables cancer 
registries to perform residential cancer cluster investigations. In California, cancer concern 
investigations are handled at the regional level with oversight provided by the California 
Cancer Registry (CCR), a program of the California Department of Public Health and the 
Surveillance, Epidemiology, and End Results (SEER) program [12]. Population-based 
cancer reporting in the Greater Bay Area began in 1973 as a part of the SEER program. In 
1988, cancer reporting became mandatory throughout California, and the CCR was 
established. In follow-up to the inquiry from a representative of the local media, we 
conducted a cancer cluster investigation that followed registry guidelines [13]. Our 
investigation focused on cancer sites suggested in the literature to be associated with TCE 
exposure: NHL, and invasive cancers of the liver and kidney [6–8].
Methods
Routinely collected cancer registry data—including address at diagnosis—were used to 
determine the number of cases diagnosed among residents in the GBACR catchment area 
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(Alameda, Contra Costa, Marin, Monterey, San Benito, San Francisco, San Mateo, Santa 
Clara, and Santa Cruz). Coding definitions for cases and populations are provided in Table 1. 
The area of concern was identified as the residential neighborhood in the MEW study area 
near Moffett Naval Air Station, an area bordered by Whisman Road, Middlefield Road, Ellis 
Street, and Highway 101 (Fig. 1). As understanding of cancer occurrence requires accurate 
counts of both the number of cancer cases (e.g., numerators) and the numbers of persons 
living in a region (e.g., denominators), our ability to assess cancer occurrence in areas 
smaller than counties depends on the availability of accurate population counts defined by 
census tracts. These detailed population counts are only collected as part of the US Census 
every 10 years. The present report uses small area-level population data from the 1990, 
2000, and 2010 US censuses. We examined cancer occurrence during three time intervals: 
1988–1995 (8 years around 1990 US Census); 1996–2005 (10 years around 2000 US 
Census); and 2006–2011 (6 years around 2010 US Census).
To determine whether cancer occurrence has been unusual, we compared the number of 
observed cancer cases that occurred among residents of the neighborhood to the number that 
would be expected to occur if residents had the same pattern of cancer occurrence as the 
entire four-county Santa Clara Region. These average annual age-, sex-, and race-specific 
incidence rates were applied to the number of residents in the neighborhood of interest 
according to the census population estimates to generate expected case counts. The observed 
and expected numbers were compared directly using the standardized incidence ratio (SIR). 
Due to statistical limitations of using small area-level data, a two-sided 99 % confidence 
interval (CI) was used to minimize the false positive error. If the 99 % CI for the SIR 
included 1.0, then any difference between observed and expected numbers were not 
considered to be statistically significant and may have been due to chance sampling 
fluctuation at the small area level.
Results
The population within the neighborhood of interest increased by about 13 % from 1990 to 
2010. Census data indicated that residents in the neighborhood of interest had an older age 
distribution in 2010 compared to 1990. Table 2 shows the estimate of NHL, liver cancer, and 
kidney cancer cases observed and expected. The observed versus expected occurrence of 
cancers of the liver and kidney were not significantly higher in the neighborhood for any 
time period examined. Further analysis revealed no significant elevations in liver and kidney 
cancer among children under age 15 years living in the neighborhood of interest (data not 
shown). From 1996 to 2005, 31 cases of NHL were observed and 17.1 were expected, a 
statistically significant elevation in incidence (SIR = 1.8, 99 % CI 1.1–2.8). From 2006 to 
2011, 17 cases of NHL were observed and 12.8 were expected, a nonsignificant elevation in 
incidence (SIR = 1.3, 99 % CI 0.6–2.4) (Table 2).
Further analysis revealed that 60 cases of NHL were diagnosed in the neighborhood of 
interest from 1988 to 2011, but case counts fluctuated from year to year and seemed to be 
clustered around selected years, 1998–2001 and 2008–2009, while case counts were 
relatively lower in the other years. Caution should be taken when comparing the crude case 
counts over time, since: (1) Generally, we expect the numbers of cases to increase over time 
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simply due to growth in the population in these tracts; (2) 1990, 2000, and 2010 census 
population estimates indicate that this neighborhood is an aging population, and increased 
age increases the expected rate of NHL. Of the 60 cases, 22 of these occurred from 1998 to 
2002; thus, the numbers of cases in the years prior to 1998 and following 2002 suggested 
that numbers were lower than the 1998–2002 period. No cases of NHL were diagnosed in 
the neighborhood of interest for the calendar years 1989, 1995, 1997, and 2007. The 
increased rate of NHL was not driven by one of the census tracts. There were no significant 
elevations in NHL among children under age 15 years living in the neighborhood of interest. 
Case counts were comparable across sexes (n = 31 male; n = 29 female).
Discussion
Cancer cluster investigations in the USA are controversial [14–18]. They garner public 
attention and involve an investment of public funds. Cancer cluster investigations are 
primarily geared toward educating the community and/or representatives of the media about 
risk factors for cancer, statistical limitations of studying a small population of individuals 
using cancer registry data, and mitigating perceived risks from potential exposures to toxic 
chemicals in communities [14, 16, 18]. Research investigating media records of suspected 
cancer cluster reports demonstrates the environmental complexities associated with cancer 
cluster epidemiology as well as the breadth of popular concern regarding a variety of issues 
including exposure types, pollution sites, and specific environmental chemicals [16]. It 
remains unclear whether efforts to identify community cancer clusters have been successful. 
In a recent systematic review of 428 cancer cluster investigations evaluating 567 cancers of 
concern over the past two decades, Goodman et al. [14] identified an increase in incidence 
for 72 (13 %) cancer categories; only three were linked to hypothesized exposures.
The present cancer cluster investigation was performed using the population-based GBACR 
in follow up to a media representative’s inquiry regarding TCE exposure in a residential 
neighborhood nearby the MEW site in Mountain View, California. These data are obtained 
from physicians, hospitals, and other cancer treatment facilities, as mandated by state law for 
the reporting of all cancer cases to the registry [19]. Our assessment compared observed 
rates of liver, kidney, and NHL cancers—cancer sites associated with TCE exposure [6, 7]—
in a residential neighborhood defined by US census tracts closest to the vapor intrusion 
pathways around the MEW site (12), to expected rates in the surrounding Santa Clara 
Region. We did not find an increased occurrence of liver or kidney cancers. A statistically 
significant increase in NHL was detected during one time period assessed, 1996–2005, but 
not before (1988–1995) or after (2006–2011). Thus, there is a lack of evidence of a 
consistent, sustained, or current elevation in NHL occurrence in this neighborhood.
To date, research investigating TCE exposure and cancer risk has focused primarily on 
occupational exposures [1, 4, 20–35]. To our knowledge, this is the first population-based 
study to investigate a potential association between residence near a source of TCE exposure 
and cancer risk. There is substantial toxicological evidence that exposure to TCE is 
associated with adverse health effects [7]. The modes of action of TCE in the carcinogenic 
process have been difficult to determine and controversial, in part due to complexities 
involving uncertainty related to TCE metabolites and pathways, exploring what effect co-
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exposures may play in modifying TCE toxicity, and setting appropriate risk thresholds [3, 5, 
10, 36, 37]. To mitigate the potential adverse health effects among residents nearby the 
MEW site due to TCE contamination, the US EPA has continued to oversee site cleanup and 
monitoring [11]. Additionally, the National Institute of Environmental Health Sciences 
(NIEHS) Superfund Research Program (SRP) has a 25-year history in developing and 
providing scientific solutions to health problems associated with Superfund sites [38].
Limitations
There are several limitations related to using cancer registry data for carrying out residential 
cancer cluster investigations. Cancer registries do not collect data on exposures. 
Additionally, registry data are limited to address at the time of diagnosis and do not contain 
information on residential history or duration of residence. Since the development of cancer 
is a multi-step process often with a long time between the initiation of the carcinogenic 
process and a clinically diagnosable cancer [39], some former MEW neighborhood residents 
will have been diagnosed with cancer after moving out of the area, and some residents will 
have been diagnosed shortly after moving into the area. Because the timeframe between 
exposure to a carcinogen and onset of disease can be years, even decades, it is not possible 
to link the elevated incidence rate in a given time period to a specific cause or putative 
exposure with these data. Further, since we are only able to define neighborhoods using 
census tract definitions, it is possible that boundaries of the three selected census tracts do 
not accurately capture the intended neighborhood, or exposure. However, if there were a 
major increase in cancer among residents who have lived in the MEW neighborhood for a 
long period of time, it may be seen in this type of investigation.
Another limitation of cancer registry data is that risk factor data are not routinely collected. 
Hence, it is not possible to adjust for environmental, occupational, and lifestyle factors that 
may independently impact cancer risk or may act as potential confounders for residents 
within the neighborhood of interest. Any observed patterns may therefore be due to 
demographic and/or risk factor contributions other than environmental contaminants [40].
Another potential limitation in our study was our inability to carry out detailed analyses of 
cancer subtypes due to statistical power considerations related to small numbers. NHL 
includes a wide range of related blood cancers that vary with respect to pathological, 
clinical, and epidemiological features, with differing characteristics and etiology [41, 42]. 
Further research may be necessary to determine whether TCE exposure may be differentially 
associated with risk of specific NHL subtypes.
It is also important to note that although the SIR for NHL was significantly increased for one 
of the three time periods examined, it was based on small numbers and any difference may 
be due to random fluctuations rather than a true excess of NHL. Rates of these relatively rare 
cancers are generally unstable in such a small population and the number of cancer cases in 
an area, like any other event, may be high simply by chance. For example, there are 7,000 
census tracts in California; even using a 99 % confidence level, at any given time 30 census 
tracts would have an apparent statistically significant increase in a particular type of cancer, 
even without any differences in the cancer risk [13].
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Summary
Using existing population-based cancer registry data, the GBACR conducted an 
investigation of cancer incidence in a residential area possibly exposed to TCE from a 
nearby Superfund site. An excess occurrence of NHL was observed during one time period 
examined. However, there was a lack of evidence for an excess of liver or kidney cancer 
occurrence for any of the time periods examined, and a lack of evidence for an excess of 
NHL during the most recent or distant time periods. The present report cannot speak to 
specific exposures incurred by residents of this neighborhood, nor the effectiveness of 
ongoing cleanup efforts occurring in and around the neighborhood of interest.
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Fig. 1. 
Residential neighborhood of interest, bounded by yellow and blue. US Census County 0608. 
2000 and 2010 US Census Tracts 5,091.08, 5,091.09, and 5,092.01; and 1990 US Census 
Tracts 5,091.04 and 5,092.01. Images adapted from google.com/maps
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Table 1
Case and neighborhood definitions, ICD-O-3 and US census tract codes
Cancer ICD-O-3 site codes ICD-O-3 morphology codes US census tract codesa
1990 2000, 2010
NHL All 9590–9597, 9670–9671, 9673, 9675, 9678–9680, 
9684, 9687–9691, 9695, 9698–9702, 9705, 9708–
9709, 9712, 9714–9719, 9724–9729, 9735, 9737–
9738, 9811–9818, 9823, 9827, 9837
Liver C22.0, C22.1, C23.9, 
C24.0–24.9
All, excluding 9050–9055 and 9590–9992 5,091.04, 5,092.01 5,091.08, 5,091.09, 5,092.01
Kidney C64.9, C65.9 All, excluding 9050–9055 and 9590–9992
http://seer.cancer.gov and http://census.gov
a
For expected case counts we: [A] used the peri-censal years and the corresponding census population for the referent region of interest to obtain 
expected 5-year cancer counts for the period around the 1990 and 2000 US Censuses and expected 4-year cancer counts for the period around the 
2010 US Census, as 2012 were not yet available (e.g., 1988–1992, 1990 Census population; 1998–2002, 2000 Census population; 2008–2011, 2010 
Census population); [B] divided by the number of peri-censal years to get an expected annual rate for the referent region (e.g., divided by 5, divided 
by 5, divided by 4); and [C] multiplied this expected annual rate for the referent region by the number of years to which these rates were applied 
(e.g., multiplied by 5, multiplied by 10, multiplied by 6)
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